Bridgebio Oncology Therapeutics, Inc. (BBOT) — S-1 Filings
All S-1 filings from Bridgebio Oncology Therapeutics, Inc.. Browse 2 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (2)
-
BridgeBio Oncology Registers 63M Shares Post-Merger, Eyes KRAS Data H2 2025
— Aug 29, 2025 Risk: high
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a clinical-stage biotechnology company focused on developing therapies for cancers driven by RAS and PI3K mutati -
Helix Acquisition Corp. II Files S-1 Registration Statement
— Jan 18, 2024 Risk: low
Helix Acquisition Corp. II (BBOT) filed a IPO Registration (S-1) with the SEC on January 18, 2024. Helix Acquisition Corp. II filed an S-1 registration statemen
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX